CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Liposonix System (Model 2)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01823653
NCT01823653N/ACompleted
CompareCT.gov

A Study to Investigate the Safety and Efficacy of Treatment of Subcutaneous Adipose Tissue in the Thighs Using the Liposonix System (Model 2)

Solta Medical·interventional·Posted Apr 4, 2013·Updated Dec 31, 2014

In Brief

A clinical study evaluating Liposonix System (Model 2) for Treatment of Adipose Tissue in the Thighs. Completed, enrolled 60 participants across 4 sites in 2 countries.

Detailed Summary

The purpose of this study is to assess the safety and efficacy of treatment with the Liposonix System (Model 2) for the circumferential reduction of subcutaneous adipose tissue (SAT) of the thighs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment of Adipose Tissue in the Thighs
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 4, 2013
Enrollment StartJul 1, 2012
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 13.2 years ago

Interventions

Liposonix System (Model 2)device

Treatment of Subcutaneous Adipose Tissue in the thighs using High Intensity Focused Ultrasound